Patient characteristics at brain parenchyma relapse
Characteristic . | Value . |
---|---|
Patients, no. | 113 |
Patient age | |
Median, y (range) | 65 (19-85) |
60 years or older | 70 (62) |
Neurologic symptoms* | |
Mental status changes | 43 (38) |
Gait/balance disturbance | 29 (26) |
Peripheral sensory/motor symptoms | 27 (24) |
Headache | 23 (20) |
Cranial nerve deficits/palsy | 19 (17) |
Seizures | 7 (6) |
Other† | 14 (12) |
Not reported | 7 (6) |
Diagnosis of brain relapse | |
Brain imaging, no biopsy | 59 (52) |
Brain imaging and biopsy | 54 (48) |
ECOG performance status | |
0 | 6 (5) |
1 | 18 (16) |
2 | 27 (24) |
3 | 36 (32) |
4 | 8 (7) |
Not reported | 18 (16) |
No. of brain lesions | |
1 | 53 (47) |
2 or more | 56 (50) |
Not reported | 4 (4) |
Involvement of deep brain structures‡ | 45 (40) |
Site of brain disease§ | |
Cerebral hemisphere | 76 (67) |
Basal ganglia | 15 (13) |
Periventricular | 15 (13) |
Cerebellum | 14 (12) |
Brainstem | 13 (11) |
Corpus callosum | 10 (9) |
Meninges | 8 (7) |
Not reported | 7 (6) |
Cerebrospinal fluid cytology | |
Negative for lymphoma cells | 56 (50) |
Positive for lymphoma cells | 11 (10) |
Not reported | 46 (40) |
Characteristic . | Value . |
---|---|
Patients, no. | 113 |
Patient age | |
Median, y (range) | 65 (19-85) |
60 years or older | 70 (62) |
Neurologic symptoms* | |
Mental status changes | 43 (38) |
Gait/balance disturbance | 29 (26) |
Peripheral sensory/motor symptoms | 27 (24) |
Headache | 23 (20) |
Cranial nerve deficits/palsy | 19 (17) |
Seizures | 7 (6) |
Other† | 14 (12) |
Not reported | 7 (6) |
Diagnosis of brain relapse | |
Brain imaging, no biopsy | 59 (52) |
Brain imaging and biopsy | 54 (48) |
ECOG performance status | |
0 | 6 (5) |
1 | 18 (16) |
2 | 27 (24) |
3 | 36 (32) |
4 | 8 (7) |
Not reported | 18 (16) |
No. of brain lesions | |
1 | 53 (47) |
2 or more | 56 (50) |
Not reported | 4 (4) |
Involvement of deep brain structures‡ | 45 (40) |
Site of brain disease§ | |
Cerebral hemisphere | 76 (67) |
Basal ganglia | 15 (13) |
Periventricular | 15 (13) |
Cerebellum | 14 (12) |
Brainstem | 13 (11) |
Corpus callosum | 10 (9) |
Meninges | 8 (7) |
Not reported | 7 (6) |
Cerebrospinal fluid cytology | |
Negative for lymphoma cells | 56 (50) |
Positive for lymphoma cells | 11 (10) |
Not reported | 46 (40) |
Values indicate no. (%) of patients unless otherwise noted.
Some patients had multiple neurologic symptoms.
Other symptoms were aphasia (n = 4), nausea and vomiting (n = 4), urinary incontinence (n = 3), dizziness (n = 2), and back pain (n = 1).
Deep brain structures included basal ganglia, brainstem, corpus callosum, and cerebellum.
Some patients had involvement of multiple brain sites.